Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
Boekel L, Hooijberg F, Vogelzang EH, Besten YR, Leeuw M, Atiqi S, van Vollenhoven RF, Wijbrandts CA, Gerritsen M, Krieckaert C, Dijkshoorn B, Bakhlakh S, Crooijmans JJ, Voskuyl A, van der Horst-Bruinsma IE, Lems W, Kuijpers TW, van Ham SM, Wieske L, Eftimov F, Kummer LY, van Dam PK, Stalman EW, Steenhuis M, Keijzer S, Cristianawati O, Keijser J, Loeff FC, Tas SW, Nurmohamed MT, Boers M, Rispens T, Wolbink G. Boekel L, et al. Among authors: van vollenhoven rf, van der horst bruinsma ie, van ham sm, van dam pk. RMD Open. 2022 Apr;8(1):e002035. doi: 10.1136/rmdopen-2021-002035. RMD Open. 2022. PMID: 35383121 Free PMC article.
Remission in SLE: closing in on the target.
van Vollenhoven RF, Voskuyl A, Morand E, Aranow C. van Vollenhoven RF, et al. Ann Rheum Dis. 2015 Dec;74(12):2103-6. doi: 10.1136/annrheumdis-2015-208231. Epub 2015 Oct 28. Ann Rheum Dis. 2015. PMID: 26511997 No abstract available.
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
l'Ami MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, Rispens T, Boers M, Wolbink GJ. l'Ami MJ, et al. Among authors: van vollenhoven rf. Ann Rheum Dis. 2018 Apr;77(4):484-487. doi: 10.1136/annrheumdis-2017-211781. Epub 2017 Sep 22. Ann Rheum Dis. 2018. PMID: 28939629 Clinical Trial.
Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
l'Ami MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, Rispens T, Boers M, Wolbink GJ. l'Ami MJ, et al. Among authors: van vollenhoven rf. Ann Rheum Dis. 2018 Oct;77(10):e68. doi: 10.1136/annrheumdis-2017-212602. Epub 2017 Nov 13. Ann Rheum Dis. 2018. PMID: 29133475 No abstract available.
Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.
Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Rusman T, et al. Among authors: van vollenhoven rf, van der horst bruinsma ie. Curr Rheumatol Rep. 2018 May 12;20(6):35. doi: 10.1007/s11926-018-0744-2. Curr Rheumatol Rep. 2018. PMID: 29754330 Free PMC article. Review.
Mixed connective tissue disease: state of the art on clinical practice guidelines.
Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R. Chaigne B, et al. Among authors: van vollenhoven rf. RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018. RMD Open. 2018. PMID: 30402271 Free PMC article.
Systemic lupus erythematosus: state of the art on clinical practice guidelines.
Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N. Tamirou F, et al. Among authors: van vollenhoven rf. RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. RMD Open. 2018. PMID: 30564454 Free PMC article. Review.
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
Berkhout LC, l'Ami MJ, Ruwaard J, Hart MH, Heer PO, Bloem K, Nurmohamed MT, van Vollenhoven RF, Boers M, Alvarez DF, Smith CH, Wolbink GJ, Rispens T. Berkhout LC, et al. Among authors: van vollenhoven rf. Sci Transl Med. 2019 Jan 30;11(477):eaat3356. doi: 10.1126/scitranslmed.aat3356. Sci Transl Med. 2019. PMID: 30700574 Clinical Trial.
IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study.
Al-Soudi A, Doorenspleet ME, Esveldt RE, Burgemeister LT, Hak AE, van den Born BJH, Tas SW, van Vollenhoven RF, Klarenbeek PL, de Vries N. Al-Soudi A, et al. Among authors: van vollenhoven rf, van den born bjh. Arthritis Res Ther. 2019 Jan 31;21(1):43. doi: 10.1186/s13075-018-1806-6. Arthritis Res Ther. 2019. PMID: 30704507 Free PMC article.
487 results